Out-licensing
Messenger Biopharma will not develop its own mRNA products and will not produce mRNA.
We are eager to out-license our technologies to pharmaceutical companies for the development of mRNA vaccines and therapies, and to CDMOs for the production of mRNA using at least one of our technologies.